V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014555 | 270010359 | null | null | Curative (C) | 2017-07-14 | 2017-07-19 | Cetuximab + Oxaliplatin + MdG Load | 02 | N | 270020354 | BEVACIZUMAB |
| 270014556 | 270010360 | 1.77 | 79.8 | Curative (C) | 2018-12-18 | 2018-12-18 | VEPEMB | 2 | null | 270020355 | BEVACIZUMAB |
| 270014557 | 270010361 | null | null | Curative (C) | 2015-08-28 | 2015-09-05 | Irinotecan | null | null | 270020360 | IRINOTECAN |
| 270014558 | 270014838 | 1.77 | 84 | Curative (C) | 2014-09-29 | 2014-10-01 | IVE | 2 | N | 270020360 | IVE |
| 270014559 | 270014838 | 1.64 | null | null | 2016-09-17 | 2016-12-31 | Cisplatin | N | Y | 270020360 | BEAM + ALEMTUZUMAB |
| 270014560 | 270010363 | 1.63 | 76.6 | Curative (C) | 2014-04-01 | 2014-04-01 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270020405 | IGEV |
| 270014561 | 270010364 | 1.79 | 58.2 | Curative (C) | 2014-01-20 | 2014-02-09 | IVE | N | N | 270020411 | IVE |
| 270014562 | 270010366 | 1.82 | null | Adjuvant (A) | 2015-01-31 | 2015-02-04 | Cetuximab + Oxaliplatin + MdG Maint | N | null | 270020427 | VEPEMB |
| 270014563 | 270010367 | 1.87 | null | Palliative (P) | 2013-06-17 | 2013-06-17 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270020440 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014564 | 270010368 | 1.62 | 104 | Curative (C) | 2017-04-28 | 2017-05-02 | AFLIBERCEPT + FU + IRINOTECAN | 02 | N | 270020481 | CETUXIMAB + OXALIPLATIN + MDG |
| 270014565 | 270010368 | 1.71 | 61.9 | Curative (C) | 2017-04-03 | 2017-04-09 | Cyclophosphamide High Dose | 02 | null | 270020481 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014566 | 270010369 | 1.62 | 85.6 | null | 2015-05-26 | 2015-05-29 | IGEV | 02 | N | 270020487 | PANITUMUMAB |
| 270014567 | 270014843 | 1.55 | 62 | Adjuvant (A) | 2016-06-30 | 2017-01-14 | GDP | 02 | N | 270020529 | GDP |
| 270014568 | 270017186 | 1.85 | 66.6 | Curative (C) | 2016-09-04 | 2016-09-22 | GEM-P | 01 | null | 270020545 | GEMCITABINE + PACLITAXEL |
| 270014569 | 270010371 | 1.51 | 57.5 | Curative (C) | 2018-07-29 | 2018-08-06 | AFLIBERCEPT + FU + IRINOTECAN | 2 | N | 270020547 | VEPEMB |
| 270014570 | 270014845 | 1.8 | 49 | Curative (C) | 2016-12-18 | 2016-12-18 | Cisplatin | N | N | 270020549 | ABVD R |
| 270014571 | 270010372 | 1.78 | 78 | Neo-adjuvant (N) | 2013-02-12 | 2013-06-05 | Panitumumab | null | null | 270020552 | IGEV |
| 270014572 | 270014846 | 1.52 | 52.7 | Palliative (P) | 2015-12-13 | 2015-12-13 | Cisplatin | 02 | Y | 270020593 | VEPEMB |
| 270014573 | 270010374 | 1.57 | 83.3 | Curative (C) | 2013-06-05 | 2013-06-05 | Oxaliplatin + Raltitrexed | 2 | N | 270020635 | ABVD R |
| 270014574 | 270010378 | 1.78 | 108 | Not known (9) | 2015-11-06 | 2015-11-09 | Cyclophosphamide High Dose | 2 | N | 270020638 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014575 | 270010379 | 1.5 | 61.5 | Curative (C) | 2016-04-12 | 2016-06-09 | Bevacizumab 7.5mg/kg | N | N | 270020638 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014576 | 270010380 | 1.8 | 118 | Curative (C) | 2013-08-28 | 2013-08-28 | AFLIBERCEPT + FU + IRINOTECAN | 2 | N | 270020640 | CISPLATIN |
| 270014577 | 270019285 | 1.62 | null | null | 2015-10-27 | 2015-10-30 | Cyclophosphamide High Dose | 02 | N | 270020661 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014578 | 270014849 | null | 142 | Curative (C) | 2016-10-21 | 2016-10-30 | Oxaliplatin + Raltitrexed | N | N | 270020669 | CISPLATIN |
| 270014579 | 270010384 | null | null | null | null | 2016-04-18 | Cisplatin 7 day | null | null | 270020683 | CARBOPLATIN |
| 270014580 | 270014850 | 1.72 | 69.6 | null | 2014-10-21 | 2014-11-07 | Gemcitabine weekly | N | N | 270020700 | BEVACIZUMAB |
| 270014581 | 270017191 | 1.69 | 81.7 | Curative (C) | 2018-02-16 | 2018-03-03 | Bevacizumab | N | N | 270020719 | VEPEMB |
| 270014582 | 270010387 | 1.7 | 82.3 | Disease modification (D) | 2017-10-10 | 2018-01-17 | Cyclophosphamide High Dose | N | N | 270020741 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014583 | 270010391 | 0 | null | Palliative (P) | 2013-06-12 | 2013-06-20 | GDP | N | N | 270020762 | GDP |
| 270014584 | 270010394 | 1.78 | 83.05 | Curative (C) | 2015-11-05 | 2015-12-02 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | 270020775 | BEAM + ALEMTUZUMAB |
| 270014585 | 270010395 | null | 57.2 | Palliative (P) | 2015-05-06 | 2015-06-30 | Cyclophosphamide High Dose | N | N | 270020775 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014586 | 270018525 | 1.72 | 85.7 | Palliative (P) | 2013-11-30 | 2013-12-10 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270020781 | PANITUMUMAB |
| 270014587 | 270010396 | 1.73 | null | Palliative (P) | 2012-12-10 | 2014-10-01 | BEAM + Alemtuzumab Allo SCT | N | N | 270020822 | GEMCITABINE |
| 270014588 | 270010398 | null | 85.6 | Curative (C) | 2017-04-27 | 2017-04-27 | R ABVD | N | null | 270020860 | CARBOPLATIN |
| 270014589 | 270010398 | 1.58 | 68.4 | Curative (C) | 2016-01-23 | 2016-02-08 | Panitumumab | 2 | N | 270020860 | IGEV |
| 270014590 | 270014857 | 1.55 | 80.3 | Curative (C) | 2016-05-02 | 2016-05-05 | GEMCITABINE | N | N | 270020891 | OXALIPLATIN + RALTITREXED |
| 270014591 | 270017196 | 1.84 | 111.7 | Palliative (P) | 2014-03-02 | 2014-03-02 | AFLIBERCEPT + FU + IRINOTECAN | 02 | N | 270020899 | BEAM + ALEMTUZUMAB |
| 270014592 | 270010400 | 1.79 | 91.5 | Palliative (P) | 2014-06-06 | 2014-06-07 | GEM-P | N | N | 270020917 | GEMCITABINE + PACLITAXEL |
| 270014593 | 270010401 | 1.65 | 89.8 | Curative (C) | 2015-02-01 | 2015-03-17 | Cyclophosphamide High Dose | N | N | 270020925 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014594 | 270010402 | 1.9 | 46.9 | Curative (C) | 2018-02-15 | 2018-02-17 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270020953 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270014595 | 270010402 | 1.63 | 57 | Adjuvant (A) | 2018-09-26 | 2018-09-26 | IVE | 02 | N | 270020953 | IVE |
| 270014596 | 270010403 | 1.7 | null | Curative (C) | 2017-09-10 | 2017-09-10 | Irinotecan | N | N | 270021016 | IRINOTECAN |
| 270014597 | 270010405 | 1.8 | null | Adjuvant (A) | null | 2017-11-19 | BEAM + Alemtuzumab Allo SCT | null | null | 270021045 | ABVD R |
| 270014598 | 270010408 | 1.72 | 110 | null | 2015-11-30 | 2015-12-09 | Bevacizumab 5mg/kg | 02 | N | 270021060 | CETUXIMAB + OXALIPLATIN + MDG |
| 270014599 | 270014862 | 1.73 | 83 | null | 2014-04-10 | 2014-07-18 | Carboplatin AUC 6 - 10 | null | null | 270021064 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014600 | 270017199 | 1.6 | 51.2 | Disease modification (D) | 2018-02-14 | 2018-04-23 | Carboplatin + Etoposide iv&po | N | N | 270021079 | BEVACIZUMAB + CAPECITABINE |
| 270014601 | 270010411 | 1.74 | 77 | Curative (C) | 2016-06-18 | 2016-07-17 | Bevacizumab + FLUOROURACIL + IRINOTECAN | N | N | 270021086 | IRINOTECAN + MDG + PANITUMUMAB |
| 270014602 | 270010412 | 1.73 | 102.7 | Curative (C) | 2013-10-17 | 2013-10-18 | RATHL TRIAL | 02 | null | 270021099 | ETOPOSIDE |
| 270014603 | 270010413 | 1.6 | 63 | Palliative (P) | 2016-09-21 | 2016-11-09 | Cisplatin + Fluorouracil + RT 5day | N | N | 270021126 | CARBOPLATIN + RT |
| 270014604 | 270010414 | 1.67 | 57 | Curative (C) | 2015-12-05 | 2015-12-11 | Cetuximab + CISPLATIN + FLUOROURACIL | 2 | N | 270021137 | DOCETAXEL |